Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$130K Buy
+11,987
New +$128K ﹤0.01% 1599
2026
Q1
Sell
-74,629
Closed -$1.22M 1930
2025
Q4
$1.22M Sell
74,629
-176,152
-70% -$2.74M 0.03% 883
2025
Q3
$3.36M Sell
250,781
-14,184
-5% -$168K 0.08% 356
2025
Q2
$3.39M Buy
+264,965
New +$3.18M 0.08% 365
2024
Q4
Sell
-115,868
Closed -$1.48M 1535
2024
Q3
$1.48M Buy
+115,868
New +$1.42M 0.09% 292
2024
Q1
Sell
-52,463
Closed -$1.3M 1658
2023
Q4
$1.3M Buy
52,463
+17,153
+49% +$335K 0.12% 226
2023
Q3
$604K Buy
+35,310
New +$588K 0.06% 493
2023
Q2
Sell
-75,441
Closed -$1.32M 1604
2023
Q1
$1.32M Buy
+75,441
New +$1.14M 0.15% 191

Other funds holding PATH

Y-Intercept (HK)'s PATH Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in UiPath (PATH) in Q2 2026: 11,987 shares worth $130K. The stake represents ﹤0.01% of the portfolio and ranks #1599 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in PATH as recently as Q4 2025.

Y-Intercept (HK) first reported a position in PATH in Q1 2023 and has held it in 8 quarters since. The position peaked at $3.39M in Q2 2025. 92 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • Y-Intercept (HK) held 11,987 shares of UiPath worth $130K as of Q2 2026.
  • UiPath was a new Y-Intercept (HK) position in Q2 2026.
  • UiPath made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1599 holding.
  • Y-Intercept (HK) first reported a position in UiPath in Q1 2023 and has held it in 8 quarters since.
  • Y-Intercept (HK)'s UiPath position peaked at $3.39M in Q2 2025.
  • 92 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.